-+ 0.00%
-+ 0.00%
-+ 0.00%

AbbVie has consolidated its leading position in the field of migraine with positive phase III study results on the treatment of menstrual migraines with atogipam.

Zhitongcaijing·09/10/2026 12:57:14
Listen to the news
AbbVie has consolidated its leading position in the field of migraine with positive phase III study results on the treatment of menstrual migraines with atogipam.